Use access key #2 to skip to page content.
$3.78 0.24 (6.78%)
10/3/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

2

Avatar morningstarboy (67.74) Submitted: 12/05/07 12:49 PM : Outperform Start Price: $9.00 MNKD Score: -32.79

As of close of business on 12/04/2007, this was a 5-star Morningstar stock that was trading below half of it's Morningstar fair value.

Report this Post Replies: 0 | Reply

Featured Broker Partners